Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy

Table 3

Comparison between patients aged ≤37 years (group 1) and patients aged >37 years (group 2). For all variables—positive values. EBV: Epstein-Barr virus; VZV: varicella zoster virus; CMV: cytomegalovirus; TBC: tuberculosis (Mantoux skin test or QuantiFERON-TB Gold).

	Group 1 (≤37 years)			Group 2 (>37 years)			value (total, group 1 versus group 2)
	Total (% +ve)	CD (% +ve)	UC (% +ve)	Total (% +ve)	CD (% +ve)	UC (% +ve)
VCA-IgG EBV	114/134 (85.1%)	68/82 (82.9%)	46/52 (88.5%)	190/202 (94.1%)	99/107 (92.5%)	91/95 (95.8%)
VZV-IgG	87/104 (83.7%)	48/59 (81.4%)	39/45 (86.7%)	144/152 (94.7%)	80/85 (94.1%)	64/67 (95.5%)
CMV-IgG	66/129 (51.2%)	37/78 (47.4%)	29/51 (56.9%)	152/199 (76.4%)	79/104 (76%)	73/95 (76.8%)
TBC	0/126 (0%)	0/80 (0%)	0/46 (0%)	21/189 (11.1%)	15/112 (13.4%)	6/77 (7.8%)